180 related articles for article (PubMed ID: 32763292)
1. Regulatory and immunomodulatory role of miR-34a in T cell immunity.
Taheri F; Ebrahimi SO; Shareef S; Reiisi S
Life Sci; 2020 Dec; 262():118209. PubMed ID: 32763292
[TBL] [Abstract][Full Text] [Related]
2. miR-34a as hub of T cell regulation networks.
Hart M; Walch-Rückheim B; Krammes L; Kehl T; Rheinheimer S; Tänzer T; Glombitza B; Sester M; Lenhof HP; Keller A; Meese E
J Immunother Cancer; 2019 Jul; 7(1):187. PubMed ID: 31311583
[TBL] [Abstract][Full Text] [Related]
3. Regulation of the MIR155 host gene in physiological and pathological processes.
Elton TS; Selemon H; Elton SM; Parinandi NL
Gene; 2013 Dec; 532(1):1-12. PubMed ID: 23246696
[TBL] [Abstract][Full Text] [Related]
4. Identification of potential miRNA-mRNA interaction network in bone marrow T cells of acquired aplastic anemia.
Lu S; Yadav AK; Qiao X
Hematology; 2020 Dec; 25(1):168-175. PubMed ID: 32338587
[No Abstract] [Full Text] [Related]
5. Identification and validation of microRNAs that synergize with miR-34a - a basis for combinatorial microRNA therapeutics.
Orellana EA; Li C; Lisevick A; Kasinski AL
Cell Cycle; 2019 Aug; 18(15):1798-1811. PubMed ID: 31258013
[TBL] [Abstract][Full Text] [Related]
6. Verification of microRNA expression in human endometrial adenocarcinoma.
Jurcevic S; Klinga-Levan K; Olsson B; Ejeskär K
BMC Cancer; 2016 Apr; 16():261. PubMed ID: 27039384
[TBL] [Abstract][Full Text] [Related]
7. The miRNA miR-34a enhances HIV-1 replication by targeting PNUTS/PPP1R10, which negatively regulates HIV-1 transcriptional complex formation.
Kapoor R; Arora S; Ponia SS; Kumar B; Maddika S; Banerjea AC
Biochem J; 2015 Sep; 470(3):293-302. PubMed ID: 26188041
[TBL] [Abstract][Full Text] [Related]
8. The role of the miR-148/-152 family in physiology and disease.
Friedrich M; Pracht K; Mashreghi MF; Jäck HM; Radbruch A; Seliger B
Eur J Immunol; 2017 Dec; 47(12):2026-2038. PubMed ID: 28880997
[TBL] [Abstract][Full Text] [Related]
9. Regulation of PD-L1: a novel role of pro-survival signalling in cancer.
Chen J; Jiang CC; Jin L; Zhang XD
Ann Oncol; 2016 Mar; 27(3):409-16. PubMed ID: 26681673
[TBL] [Abstract][Full Text] [Related]
10. Transcriptome-wide characterization of the endogenous miR-34A-p53 tumor suppressor network.
Samuel N; Wilson G; Id Said B; Pan A; Deblois G; Fischer NW; Alexandrova R; Casallo G; Paton T; Lupien M; Gariepy J; Merico D; Hudson TJ; Malkin D
Oncotarget; 2016 Aug; 7(31):49611-49622. PubMed ID: 27391063
[TBL] [Abstract][Full Text] [Related]
11. miR-34a-dependent overexpression of Per1 decreases cholangiocarcinoma growth.
Han Y; Meng F; Venter J; Wu N; Wan Y; Standeford H; Francis H; Meininger C; Greene J; Trzeciakowski JP; Ehrlich L; Glaser S; Alpini G
J Hepatol; 2016 Jun; 64(6):1295-304. PubMed ID: 26923637
[TBL] [Abstract][Full Text] [Related]
12. Functions of miR126 and innate immune response.
Bai Y; Lu W; Han N; Bian H; Zhu M
Yi Chuan; 2014 Jul; 36(7):631-6. PubMed ID: 25076026
[TBL] [Abstract][Full Text] [Related]
13. Effect of microRNA-34a in cell cycle, differentiation, and apoptosis: a review.
Chen F; Hu SJ
J Biochem Mol Toxicol; 2012 Feb; 26(2):79-86. PubMed ID: 22162084
[TBL] [Abstract][Full Text] [Related]
14. MiR-34a promotes DCs development and inhibits their function on T cell activation by targeting WNT1.
Huang A; Yang Y; Chen S; Xia F; Sun D; Fang D; Xiong S; Jin L; Zhang J
Oncotarget; 2017 Mar; 8(10):17191-17201. PubMed ID: 28199987
[TBL] [Abstract][Full Text] [Related]
15. Alternative mechanisms of miR-34a regulation in cancer.
Slabáková E; Culig Z; Remšík J; Souček K
Cell Death Dis; 2017 Oct; 8(10):e3100. PubMed ID: 29022903
[TBL] [Abstract][Full Text] [Related]
16. MiR-137 and miR-34a directly target Snail and inhibit EMT, invasion and sphere-forming ability of ovarian cancer cells.
Dong P; Xiong Y; Watari H; Hanley SJ; Konno Y; Ihira K; Yamada T; Kudo M; Yue J; Sakuragi N
J Exp Clin Cancer Res; 2016 Sep; 35(1):132. PubMed ID: 27596137
[TBL] [Abstract][Full Text] [Related]
17. miR-150, p53 protein and relevant miRNAs consist of a regulatory network in NSCLC tumorigenesis.
Wang DT; Ma ZL; Li YL; Wang YQ; Zhao BT; Wei JL; Qi X; Zhao XT; Jin YX
Oncol Rep; 2013 Jul; 30(1):492-8. PubMed ID: 23670238
[TBL] [Abstract][Full Text] [Related]
18. miR-34a: a new player in the regulation of T cell function by modulation of NF-κB signaling.
Hart M; Walch-Rückheim B; Friedmann KS; Rheinheimer S; Tänzer T; Glombitza B; Sester M; Lenhof HP; Hoth M; Schwarz EC; Keller A; Meese E
Cell Death Dis; 2019 Jan; 10(2):46. PubMed ID: 30718475
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-34a and its target genes: Key factors in cancer multidrug resistance.
Ghandadi M; Sahebkar A
Curr Pharm Des; 2016; 22(7):933-9. PubMed ID: 26648462
[TBL] [Abstract][Full Text] [Related]
20. The role of miR-183 cluster in immunity.
Ichiyama K; Dong C
Cancer Lett; 2019 Feb; 443():108-114. PubMed ID: 30529154
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
